Minofer

Minofer may be available in the countries listed below.

Ingredient matches for Minofer

Folic Acid

Folic Acid is reported as an ingredient of Minofer in the following countries:

• India

International Drug Name Search

Alendronate EG

Alendronate EG may be available in the countries listed below.

Ingredient matches for Alendronate EG

Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronate EG in the following countries:

• Belgium

International Drug Name Search

Rimantadine

Pronunciation: ri-MAN-ta-deen
Generic Name: Rimantadine
Brand Name: Flumadine

Rimantadine is used for:

Preventing and treating certain types of flu in adults. It is also used to prevent certain types of flu in children. It may also be used for other conditions as determined by your doctor.

Rimantadine is an antiviral agent. Exactly how it works is not known. It may block reproduction of the virus.

Do NOT use Rimantadine if:

• you are allergic to any ingredient in Rimantadine or to any adamantane medicine (eg, amantadine)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Rimantadine:

Some medical conditions may interact with Rimantadine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of liver problems, kidney problems, or seizures


• if you have taken any adamantane medicine (eg, amantadine) for the flu and it has not worked


• if you will be receiving a live nasal flu vaccine, or have received one within the past 14 days

Some MEDICINES MAY INTERACT with Rimantadine. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Acetaminophen or aspirin because they may decrease Rimantadine's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rimantadine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Rimantadine:

Use Rimantadine as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Rimantadine by mouth with or without food.


• If you are taking Rimantadine to treat the flu, start taking it as soon as possible. It works best if you begin taking it within 48 hours after you start having flu symptoms.


• Take Rimantadine for the full course of treatment. Do not miss any doses.


• If you miss a dose of Rimantadine, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Rimantadine.

Important safety information:

• Rimantadine may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Rimantadine with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Rimantadine only works against certain types of the flu; it does not treat other viral infections (eg, the common cold) or infections caused by bacteria.


• Be sure to use Rimantadine for the full course of treatment. If you do not, the medicine may not work as well. The virus could also become less sensitive to this or other medicines. This could make the infection harder to treat in the future.


• Check with your doctor if you will be receiving a live nasal flu vaccine or have received one within the past 14 days. You should usually not start taking Rimantadine until 2 weeks after you receive a live nasal flu vaccine. You should usually not receive a live nasal flu vaccine within 48 hours after you stop taking Rimantadine.


• Use Rimantadine with caution in the ELDERLY; they may be more sensitive to its effects, especially dizziness, headache, anxiety, weakness, tiredness, nausea, vomiting, and stomach pain.


• Rimantadine should not be used to treat the flu in CHILDREN younger than 17 years old or used to prevent the flu in children younger than 1 year old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Rimantadine while you are pregnant. It is not known if Rimantadine is found in breast milk. Do not breast-feed while taking Rimantadine.

Possible side effects of Rimantadine:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; dry mouth; headache; loss of appetite; nausea; nervousness; stomach pain; tiredness; trouble sleeping; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; depression; fast or irregular heartbeat; hallucinations; seizures; swelling of the hands, ankles, or feet; tremor; trouble walking.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Rimantadine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include agitation; hallucination; irregular heartbeat.

Proper storage of Rimantadine:

Store Rimantadine at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rimantadine out of the reach of children and away from pets.

General information:

• If you have any questions about Rimantadine, please talk with your doctor, pharmacist, or other health care provider.


• Rimantadine is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rimantadine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rimantadine resources

• Rimantadine Side Effects (in more detail)
• Rimantadine Dosage
• Rimantadine Use in Pregnancy & Breastfeeding
• Drug Images
• Rimantadine Drug Interactions
• Rimantadine Support Group
• 0 Reviews for Rimantadine - Add your own review/rating

• Rimantadine Prescribing Information (FDA)


• rimantadine Advanced Consumer (Micromedex) - Includes Dosage Information


• rimantadine Concise Consumer Information (Cerner Multum)


• Flumadine Monograph (AHFS DI)


• Flumadine Prescribing Information (FDA)

Compare Rimantadine with other medications

• Influenza A
• Influenza Prophylaxis

Ketorolaco Naturgen

Ketorolaco Naturgen may be available in the countries listed below.

Ingredient matches for Ketorolaco Naturgen

Ketorolac

Ketorolac is reported as an ingredient of Ketorolaco Naturgen in the following countries:

• Peru

International Drug Name Search

Adimod

Adimod may be available in the countries listed below.

Ingredient matches for Adimod

Pidotimod

Pidotimod is reported as an ingredient of Adimod in the following countries:

• Costa Rica


• Dominican Republic


• El Salvador


• Guatemala


• Honduras


• Mexico


• Panama

International Drug Name Search

Veyxid

Veyxid may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Veyxid

Benzylpenicillin

Benzylpenicillin monohydrate (a derivative of Benzylpenicillin) is reported as an ingredient of Veyxid in the following countries:

• Germany

International Drug Name Search

Acébutolol Teva

Acébutolol Teva may be available in the countries listed below.

Ingredient matches for Acébutolol Teva

Acebutolol

Acebutolol hydrochloride (a derivative of Acebutolol) is reported as an ingredient of Acébutolol Teva in the following countries:

• France

International Drug Name Search

Nasengel AL

Nasengel AL may be available in the countries listed below.

Ingredient matches for Nasengel AL

Xylometazoline

Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Nasengel AL in the following countries:

• Germany

International Drug Name Search

benzoyl peroxide and sodium hyaluronate topical kit

Generic Name: benzoyl peroxide and sodium hyaluronate topical kit (BEN zoe il per OX ide and SOE dee um HYE al ure ON ate)

Brand Names: Zacare

What is benzoyl peroxide and sodium hyaluronate topical?

Benzoyl peroxide has an antibacterial effect. It also has a mild drying effect, which allows excess oils and dirt to be easily washed away from the skin.

Sodium hyaluronate is a lubricant that restores moisture to the skin.

Benzoyl peroxide and sodium hyaluronate topical are used together to treat severe acne along with dry or scaly skin.

Benzoyl peroxide and sodium hyaluronate topical may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about benzoyl peroxide and sodium hyaluronate topical?

This medication comes as a kit containing benzoyl peroxide lotion and sodium hyaluronate gel.

You should not use this medication if you are allergic to benzoyl peroxide or sodium hyaluronate. Do not use this medication on a child younger than 12 years old without the advice of a doctor. Avoid getting this medication on your lips or in your mouth, nose, or eyes. If it does get into any of these areas, rinse with water.

Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.

It may take up to 3 weeks of using this medicine before your symptoms improve. Talk with your doctor if your symptoms do not improve. The best results may be seen after 8 to 12 weeks of use. Do not use other medicated skin products unless your doctor has told you to.

Stop using benzoyl peroxide and sodium hyaluronate and call your doctor at once if you have severe stinging or burning of your skin.

What should I discuss with my healthcare provider before using benzoyl peroxide and sodium hyaluronate topical?

You should not use this medication if you are allergic to benzoyl peroxide or sodium hyaluronate. FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether benzoyl peroxide and sodium hyaluronate passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child younger than 12 years old without the advice of a doctor.

How should I use benzoyl peroxide and sodium hyaluronate topical?

This medication comes as a kit containing benzoyl peroxide lotion and sodium hyaluronate gel.

Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.

Shake the benzoyl peroxide lotion well just before each use. Wet the skin before applying the benzoyl peroxide cleansing lotion. Work the lotion into a lather and rinse thoroughly. Gently the skin dry.

During your first week of treatment, wash the affected skin with the benzoyl peroxide lotion once daily. After the first week, wash the skin twice daily.

The sodium hyaluronate gel may be applied 2 or 3 times daily. Follow your doctor's instructions. Apply a liberal amount of the gel and rub it in thoroughly.

Do not cover the treated skin area unless your doctor has told you to.

It may take up to 3 weeks of using this medicine before your symptoms improve. Talk with your doctor if your symptoms do not improve. The best results may be seen after 8 to 12 weeks of use. Do not use other medicated skin products unless your doctor has told you to.

Store benzoyl peroxide and sodium hyaluronate at room temperature away from moisture and heat. Keep the lotion bottle and ointment tube tightly closed when not in use.

What happens if I miss a dose?

Apply the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to apply the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of benzoyl peroxide and sodium hyaluronate applied to the skin is not likely to cause life-threatening symptoms.

What should I avoid while using benzoyl peroxide and sodium hyaluronate topical?

Avoid getting this medication on your lips or in your mouth, nose, or eyes. If it does get into any of these areas, rinse with water.

Avoid using benzoyl peroxide and sodium hyaluronate topical on sunburned, windburned, dry, chapped, irritated, or broken skin.

Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.

Do not use other medicated skin products unless your doctor has told you to.

Benzoyl peroxide and sodium hyaluronate topical side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using benzoyl peroxide and sodium hyaluronate and call your doctor at once if you have severe stinging or burning of your skin.

Less serious side effects may include:

• 
  

  redness or peeling of treated skin;

  
  


• 
  

  mild burning or stinging; or

  
  


• 
  

  dry skin.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect benzoyl peroxide and sodium hyaluronate topical?

It is not likely that other drugs you take orally or inject will have an effect on topically applied benzoyl peroxide and sodium hyaluronate. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More benzoyl peroxide and sodium hyaluronate topical kit resources

• Benzoyl peroxide and sodium hyaluronate topical kit Use in Pregnancy & Breastfeeding
• Benzoyl peroxide and sodium hyaluronate topical kit Drug Interactions
• Benzoyl peroxide and sodium hyaluronate topical kit Support Group
• 0 Reviews for Benzoyl peroxide and sodium hyaluronate kit - Add your own review/rating

Compare benzoyl peroxide and sodium hyaluronate topical kit with other medications

• Acne

Where can I get more information?

• Your pharmacist can provide more information about benzoyl peroxide and sodium hyaluronate topical.

Pravastatina Tarbis

Pravastatina Tarbis may be available in the countries listed below.

Ingredient matches for Pravastatina Tarbis

Pravastatin

Pravastatin is reported as an ingredient of Pravastatina Tarbis in the following countries:

• Spain

International Drug Name Search

Donezepil Nucleus

Donezepil Nucleus may be available in the countries listed below.

Ingredient matches for Donezepil Nucleus

Donepezil

Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Donezepil Nucleus in the following countries:

• Slovakia

International Drug Name Search

Koate-DVI

In the US, Koate-DVI (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

US matches:

• Koate-DVI human

Ingredient matches for Koate-DVI

Coagulation Factor VIII, Human

Coagulation Factor VIII, Human is reported as an ingredient of Koate-DVI in the following countries:

• Chile


• Georgia


• Hong Kong


• Indonesia


• Israel


• Philippines


• Russian Federation


• Taiwan


• Turkey

International Drug Name Search

Siprox

Siprox may be available in the countries listed below.

Ingredient matches for Siprox

Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Siprox in the following countries:

• Iceland


• Malta


• Oman

International Drug Name Search

Afungil

Afungil may be available in the countries listed below.

Ingredient matches for Afungil

Fluconazole

Fluconazole is reported as an ingredient of Afungil in the following countries:

• Dominican Republic


• Guatemala


• Mexico


• Panama

International Drug Name Search

Kalymin

Kalymin may be available in the countries listed below.

Ingredient matches for Kalymin

Pyridostigmine

Pyridostigmine Bromide is reported as an ingredient of Kalymin in the following countries:

• Bulgaria


• Estonia


• Germany


• Latvia


• Russian Federation

International Drug Name Search

Oniz

Oniz may be available in the countries listed below.

Ingredient matches for Oniz

Ornidazole

Ornidazole is reported as an ingredient of Oniz in the following countries:

• Bangladesh


• India

International Drug Name Search

Ciprobay XR

Ciprobay XR may be available in the countries listed below.

Ingredient matches for Ciprobay XR

Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Ciprobay XR in the following countries:

• Bulgaria

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprobay XR in the following countries:

• South Africa

International Drug Name Search

Roxithromycine Qualimed

Roxithromycine Qualimed may be available in the countries listed below.

Ingredient matches for Roxithromycine Qualimed

Roxithromycin

Roxithromycin is reported as an ingredient of Roxithromycine Qualimed in the following countries:

• France

International Drug Name Search

Ketobron

Ketobron may be available in the countries listed below.

Ingredient matches for Ketobron

Ketotifen

Ketotifen is reported as an ingredient of Ketobron in the following countries:

• Colombia

International Drug Name Search

Ketoconazol Actavis

Ketoconazol Actavis may be available in the countries listed below.

Ingredient matches for Ketoconazol Actavis

Ketoconazole

Ketoconazole is reported as an ingredient of Ketoconazol Actavis in the following countries:

• Netherlands

International Drug Name Search

Ostenel

Ostenel may be available in the countries listed below.

Ingredient matches for Ostenel

Risedronic Acid

Risedronic Acid is reported as an ingredient of Ostenel in the following countries:

• Tunisia

International Drug Name Search

Diclotaren Gel

Diclotaren Gel may be available in the countries listed below.

Ingredient matches for Diclotaren Gel

Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Diclotaren Gel in the following countries:

• Chile

International Drug Name Search

Lisinopril / Hydrochlorothiazide Biogaran

Lisinopril/Hydrochlorothiazide Biogaran may be available in the countries listed below.

Ingredient matches for Lisinopril/Hydrochlorothiazide Biogaran

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisinopril/Hydrochlorothiazide Biogaran in the following countries:

• France

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril/Hydrochlorothiazide Biogaran in the following countries:

• France

International Drug Name Search

Nafin

Nafin may be available in the countries listed below.

Ingredient matches for Nafin

Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Nafin in the following countries:

• South Africa

International Drug Name Search

Kvetiapin Merck

Kvetiapin Merck may be available in the countries listed below.

Ingredient matches for Kvetiapin Merck

Quetiapine

Quetiapine is reported as an ingredient of Kvetiapin Merck in the following countries:

• Slovenia

International Drug Name Search

Diasera L

Diasera L may be available in the countries listed below.

Ingredient matches for Diasera L

Isosorbide Dinitrate

Isosorbide Dinitrate is reported as an ingredient of Diasera L in the following countries:

• Japan

International Drug Name Search

Rosalgin Pronto

Rosalgin Pronto may be available in the countries listed below.

Ingredient matches for Rosalgin Pronto

Benzydamine

Benzydamine hydrochloride (a derivative of Benzydamine) is reported as an ingredient of Rosalgin Pronto in the following countries:

• Spain

International Drug Name Search

DNCG Trom

DNCG Trom may be available in the countries listed below.

Ingredient matches for DNCG Trom

Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of DNCG Trom in the following countries:

• Germany

International Drug Name Search

Klonatropina

Klonatropina may be available in the countries listed below.

Ingredient matches for Klonatropina

Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Klonatropina in the following countries:

• Peru

International Drug Name Search

Fibrolip

Fibrolip may be available in the countries listed below.

Ingredient matches for Fibrolip

Gemfibrozil

Gemfibrozil is reported as an ingredient of Fibrolip in the following countries:

• Greece

International Drug Name Search

Nitroglycerin Slocaps

Ingredient matches for Nitroglycerin Slocaps

Nitroglycerin

Nitroglycerin is reported as an ingredient of Nitroglycerin Slocaps in the following countries:

• United States

International Drug Name Search

Atropt

Atropt may be available in the countries listed below.

Ingredient matches for Atropt

Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Atropt in the following countries:

• Australia


• New Zealand

International Drug Name Search

Meglimid

Meglimid may be available in the countries listed below.

Ingredient matches for Meglimid

Glimepiride

Glimepiride is reported as an ingredient of Meglimid in the following countries:

• Croatia (Hrvatska)


• Latvia


• Lithuania


• Slovakia

International Drug Name Search

Triofan Allergie

Triofan Allergie may be available in the countries listed below.

Ingredient matches for Triofan Allergie

Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Triofan Allergie in the following countries:

• Switzerland

International Drug Name Search

Cefixim Stada

Cefixim Stada may be available in the countries listed below.

Ingredient matches for Cefixim Stada

Cefixime

Cefixime is reported as an ingredient of Cefixim Stada in the following countries:

• Vietnam

Cefixime trihydrate (a derivative of Cefixime) is reported as an ingredient of Cefixim Stada in the following countries:

• Germany

International Drug Name Search

Zalopram

Zalopram may be available in the countries listed below.

Ingredient matches for Zalopram

Citalopram

Citalopram is reported as an ingredient of Zalopram in the following countries:

• Dominican Republic

International Drug Name Search

Hydrocortisone Sodium Succinate

Hydrocortisone Sodium Succinate may be available in the countries listed below.

Ingredient matches for Hydrocortisone Sodium Succinate

Hydrocortisone

Hydrocortisone Sodium Succinate (BANM, JAN) is known as Hydrocortisone in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tetramycin

Tetramycin may be available in the countries listed below.

Ingredient matches for Tetramycin

Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Tetramycin in the following countries:

• Bangladesh

International Drug Name Search

Amloreg

Amloreg may be available in the countries listed below.

Ingredient matches for Amloreg

Amlodipine

Amlodipine mesilate (a derivative of Amlodipine) is reported as an ingredient of Amloreg in the following countries:

• Luxembourg

International Drug Name Search

Unipres

In the US, Unipres is a member of the drug class antihypertensive combinations and is used to treat High Blood Pressure.

Ingredient matches for Unipres

Nitrendipine

Nitrendipine is reported as an ingredient of Unipres in the following countries:

• Czech Republic


• Hungary


• Lithuania


• Romania


• Slovenia

International Drug Name Search

Kolkatriol

Kolkatriol may be available in the countries listed below.

Ingredient matches for Kolkatriol

Calcitriol

Calcitriol is reported as an ingredient of Kolkatriol in the following countries:

• Indonesia

International Drug Name Search

Kolsuspension

Kolsuspension may be available in the countries listed below.

Ingredient matches for Kolsuspension

Charcoal

Charcoal, Activated is reported as an ingredient of Kolsuspension in the following countries:

• Sweden


• Switzerland

International Drug Name Search

Konakion MM

Konakion MM may be available in the countries listed below.

Ingredient matches for Konakion MM

Phytomenadione

Phytomenadione is reported as an ingredient of Konakion MM in the following countries:

• New Zealand


• Peru


• Slovenia

International Drug Name Search

Areloger

Areloger may be available in the countries listed below.

Ingredient matches for Areloger

Meloxicam

Meloxicam is reported as an ingredient of Areloger in the following countries:

• Ireland

International Drug Name Search

Konakion

In some countries, this medicine may only be approved for veterinary use.

In the US, Konakion (phytonadione systemic) is a member of the drug class vitamins and is used to treat Hypoprothrombinemia - Anticoagulant Induced, Hypoprothrombinemia - Not Associated with Anticoagulant Therapy, Hypoprothrombinemia - Prophylaxis and Vitamin K Deficiency.

US matches:

• Konakion

UK matches:

• Konakion MM
• Konakion MM Paediatric Ampoules 2mg/0.2ml
• Konakion MM (SPC)
• Konakion MM Paediatric (SPC)

Ingredient matches for Konakion

Phytomenadione

Phytomenadione is reported as an ingredient of Konakion in the following countries:

• Algeria


• Argentina


• Bahrain


• Bangladesh


• Belgium


• Bosnia & Herzegowina


• Botswana


• Brazil


• Bulgaria


• Chile


• Colombia


• Croatia (Hrvatska)


• Cyprus


• Dominican Republic


• Ecuador


• Egypt


• Ethiopia


• Finland


• Germany


• Ghana


• Greece


• Haiti


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Jamaica


• Jordan


• Kenya


• Kuwait


• Latvia


• Lebanon


• Libya


• Luxembourg


• Malawi


• Malaysia


• Mali


• Mauritius


• Mexico


• Morocco


• Namibia


• Netherlands


• New Zealand


• Norway


• Oman


• Pakistan


• Paraguay


• Philippines


• Qatar


• Saudi Arabia


• Serbia


• Singapore


• South Africa


• Spain


• Sri Lanka


• Sudan


• Sweden


• Switzerland


• Tanzania


• Thailand


• Turkey


• Uganda


• United Arab Emirates


• United Kingdom


• Uruguay


• Zambia


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Asodocel

Asodocel may be available in the countries listed below.

Ingredient matches for Asodocel

Docetaxel

Docetaxel is reported as an ingredient of Asodocel in the following countries:

• Argentina

Docetaxel trihydrate (a derivative of Docetaxel) is reported as an ingredient of Asodocel in the following countries:

• Argentina

International Drug Name Search

Ferro sanol gyn

Ferro sanol gyn may be available in the countries listed below.

Ingredient matches for Ferro sanol gyn

Ferrous Glycine Sulfate

Ferrous Glycine Sulfate is reported as an ingredient of Ferro sanol gyn in the following countries:

• Germany

Folic Acid

Folic Acid is reported as an ingredient of Ferro sanol gyn in the following countries:

• Germany

International Drug Name Search

Céfotaxime Mylan

Céfotaxime Mylan may be available in the countries listed below.

Ingredient matches for Céfotaxime Mylan

Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Céfotaxime Mylan in the following countries:

• France

International Drug Name Search

Prograf

Prograf is a brand name of tacrolimus, approved by the FDA in the following formulation(s):

PROGRAF (tacrolimus - capsule; oral)

• 
  Manufacturer: ASTELLAS
  
  Approval date: April 8, 1994
  
  Strength(s): EQ 1MG BASE ^[AB], EQ 5MG BASE ^[RLD][AB]


• 
  Manufacturer: ASTELLAS
  
  Approval date: August 24, 1998
  
  Strength(s): EQ 0.5MG BASE ^[AB]

PROGRAF (tacrolimus - injectable; injection)

• 
  Manufacturer: ASTELLAS
  
  Approval date: April 8, 1994
  
  Strength(s): EQ 5MG BASE/ML ^[RLD]

Has a generic version of Prograf been approved?

A generic version of Prograf has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Prograf and have been approved by the FDA:

tacrolimus capsule; oral

• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: May 12, 2010
  
  Strength(s): EQ 0.5MG BASE ^[AB], EQ 1MG BASE ^[AB], EQ 5MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: September 17, 2010
  
  Strength(s): EQ 0.5MG BASE ^[AB], EQ 1MG BASE ^[AB], EQ 5MG BASE ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: August 10, 2009
  
  Strength(s): EQ 0.5MG BASE ^[AB], EQ 1MG BASE ^[AB], EQ 5MG BASE ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: July 1, 2010
  
  Strength(s): EQ 5MG BASE ^[AB]

Note: No generic formulation of the following product is available.

• tacrolimus - injectable; injection

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prograf. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Prograf.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • March 29, 2013 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Prograf Consumer Information (Drugs.com)
• Prograf Consumer Information (Wolters Kluwer)
• Prograf Capsules Consumer Information (Wolters Kluwer)
• Prograf Consumer Information (Cerner Multum)
• Prograf Advanced Consumer Information (Micromedex)
• Prograf AHFS DI Monographs (ASHP)
• Tacrolimus Consumer Information (Wolters Kluwer)
• Tacrolimus Capsules Consumer Information (Wolters Kluwer)
• Tacrolimus Consumer Information (Cerner Multum)
• Tacrolimus Oral, Intravenous Advanced Consumer Information (Micromedex)
• Tacrolimus AHFS DI Monographs (ASHP)

Abelcet

In the US, Abelcet (amphotericin b lipid complex systemic) is a member of the drug class polyenes and is used to treat Aspergillosis - Aspergilloma, Aspergillosis - Invasive, Blastomycosis, Candida Infections - Systemic, Coccidioidomycosis, Cryptococcosis, Histoplasmosis and Leishmaniasis.

US matches:

• Abelcet

UK matches:

• Abelcet
• Abelcet (Cephalon (UK) Limited) (SPC)

Ingredient matches for Abelcet

Amphotericin B

Amphotericin B is reported as an ingredient of Abelcet in the following countries:

• Belgium


• Poland


• Sweden

Amphotericin B phospholipid complex (a derivative of Amphotericin B) is reported as an ingredient of Abelcet in the following countries:

• Argentina


• Australia


• Austria


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hungary


• Iceland


• Ireland


• Italy


• Luxembourg


• Netherlands


• Norway


• Oman


• Singapore


• Slovakia


• Spain


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Stalene

Stalene may be available in the countries listed below.

Ingredient matches for Stalene

Fluconazole

Fluconazole is reported as an ingredient of Stalene in the following countries:

• Singapore

International Drug Name Search

Pratol

Pratol may be available in the countries listed below.

Ingredient matches for Pratol

Felodipine

Felodipine is reported as an ingredient of Pratol in the following countries:

• Romania

International Drug Name Search

Apo-Tiaprofenic

Apo-Tiaprofenic may be available in the countries listed below.

Ingredient matches for Apo-Tiaprofenic

Tiaprofenic Acid

Tiaprofenic Acid is reported as an ingredient of Apo-Tiaprofenic in the following countries:

• Canada

International Drug Name Search

Heparin Fresenius

Heparin Fresenius may be available in the countries listed below.

Ingredient matches for Heparin Fresenius

Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Heparin Fresenius in the following countries:

• Switzerland

International Drug Name Search

Cloram Hemidexa Llorens

Cloram Hemidexa Llorens may be available in the countries listed below.

Ingredient matches for Cloram Hemidexa Llorens

Chloramphenicol

Chloramphenicol is reported as an ingredient of Cloram Hemidexa Llorens in the following countries:

• Spain

Dexamethasone

Dexamethasone phosphate (a derivative of Dexamethasone) is reported as an ingredient of Cloram Hemidexa Llorens in the following countries:

• Spain

International Drug Name Search

TFC

TFC may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for TFC

Tetracycline

Tetracycline complex with sodium metaphosphate (a derivative of Tetracycline) is reported as an ingredient of TFC in the following countries:

• South Africa

International Drug Name Search

Qualiphor

Qualiphor may be available in the countries listed below.

Ingredient matches for Qualiphor

Cefaclor

Cefaclor is reported as an ingredient of Qualiphor in the following countries:

• Hong Kong

International Drug Name Search

Kapidex

In the US, Kapidex (dexlansoprazole systemic) is a member of the drug class proton pump inhibitors and is used to treat Barrett's Esophagus, Erosive Esophagitis and GERD.

US matches:

• Kapidex


• Kapidex Delayed-Release Capsules

Ingredient matches for Kapidex

Dexlansoprazole

Dexlansoprazole is reported as an ingredient of Kapidex in the following countries:

• United States

International Drug Name Search

Badesalz

Badesalz may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Badesalz

Propoxur

Propoxur is reported as an ingredient of Badesalz in the following countries:

• Germany

International Drug Name Search

Topinmate

Topinmate may be available in the countries listed below.

Ingredient matches for Topinmate

Topiramate

Topiramate is reported as an ingredient of Topinmate in the following countries:

• Taiwan

International Drug Name Search

Diclofenac All Pro

Diclofenac All Pro may be available in the countries listed below.

Ingredient matches for Diclofenac All Pro

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac All Pro in the following countries:

• Argentina

International Drug Name Search

Olexa

Olexa may be available in the countries listed below.

Ingredient matches for Olexa

Olanzapine

Olanzapine is reported as an ingredient of Olexa in the following countries:

• Georgia


• India

International Drug Name Search

Onglyza

Onglyza is a brand name of saxagliptin, approved by the FDA in the following formulation(s):

ONGLYZA (saxagliptin hydrochloride - tablet; oral)

• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: July 31, 2009
  
  Strength(s): EQ 2.5MG BASE, EQ 5MG BASE ^[RLD]

Has a generic version of Onglyza been approved?

No. There is currently no therapeutically equivalent version of Onglyza available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Onglyza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
  Patent 6,395,767
  Issued: May 28, 2002
  Inventor(s): Jeffrey A.; Robl & Richard B.; Sulsky & David J.; Augeri & David R.; Magnin & Lawrence G.; Hamann & David A.; Betebenner
  Assignee(s): Bristol-Myers Squibb Company
  Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula where x is 0 or 1 and y is 0 or 1 (provided that x=1 when y=0 and x=0 when y=1); n is 0 or 1; X is H or CN; and wherein R1, R2, R3 and R4 are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor *or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.
  
  Patent expiration dates:
  
  
  • February 16, 2021
    
    ✓ 
    Patent use: METHOD FOR TREATING TYPE II DIABETES BY ADMINISTERING SAXAGLIPTIN
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Coated tablet formulation and method
  Patent 7,951,400
  Issued: May 31, 2011
  Inventor(s): Desai; Divyakant S. & Li; Bing V.
  Assignee(s): Bristol-Myers Squibb Company
  A coated tablet formulation is provided which includes a medicament such as the DPP4-inhibitor, saxaglipitin or its HCl salt, which is subject to intra-molecular cyclization, which formulation includes a tablet core containing one or more fillers, and other conventional excipients, which tablet core includes a coating thereon which may include two or more layers, at least one layer of which is an inner seal coat layer which is formed of one or more coating polymers, a second layer of which is formed of medicament which is the DPP4-inhibitor and one or more coating polymers, and an optional, but preferable third outer protective layer which is formed of one or more coating polymers. A method for forming the coated tablet is also provided.
  
  Patent expiration dates:
  
  
  • November 30, 2028
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 16, 2013 - CHANGES ARE BASED ON RESULTS FROM STUDY CV181057
  
  
  • July 31, 2014 - NEW CHEMICAL ENTITY
  
  

See also...

• Onglyza Consumer Information (Drugs.com)
• Onglyza Consumer Information (Wolters Kluwer)
• Onglyza Consumer Information (Cerner Multum)
• Onglyza Advanced Consumer Information (Micromedex)
• Saxagliptin Consumer Information (Wolters Kluwer)
• Saxagliptin Consumer Information (Cerner Multum)
• Saxagliptin Advanced Consumer Information (Micromedex)

Propylthiouracil PCH

Propylthiouracil PCH may be available in the countries listed below.

Ingredient matches for Propylthiouracil PCH

Propylthiouracil

Propylthiouracil is reported as an ingredient of Propylthiouracil PCH in the following countries:

• Netherlands

International Drug Name Search

Onxol

Generic Name: paclitaxel (PAK li TAK sel)

Brand Names: Onxol, Taxol

What is Onxol (paclitaxel)?

Paclitaxel is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body.

Paclitaxel is used to treat breast cancer, lung cancer, and ovarian cancer. It is also used to treat AIDS-related Kaposi's sarcoma.

Paclitaxel may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about Onxol (paclitaxel)?

Do not use this medication without telling your doctor if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment. You should not be given this medication if you are allergic to paclitaxel, or to other medications that contain an ingredient called Cremophor EL (polyoxyethylated castor oil). This includes cyclosporine (Gengraf, Neoral, Sandimmune) and teniposide (Vumon).

Before you receive paclitaxel, tell your doctor if you have liver disease, heart disease, or a severely weak immune system.

Paclitaxel can lower blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Do not miss any scheduled appointments.

There are many other medicines that can interact with paclitaxel. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor. Keep a list with you of all the medicines you use and show this list to any doctor or other healthcare provider who treats you.

What should I discuss with my healthcare provider before receiving Onxol (paclitaxel)?

You should not be given this medication if you are allergic to paclitaxel, or to other medications that contain an ingredient called Cremophor EL (polyoxyethylated castor oil). This includes cyclosporine (Gengraf, Neoral, Sandimmune) and teniposide (Vumon).

Before you receive paclitaxel, tell your doctor if you are allergic to any drugs, or if you have:

• liver disease;


• 
  

  heart disease; or

  
  


• 
  

  a severely weak immune system.

  
  

If you have any of these conditions, you may need a dose adjustment or special tests to safely receive paclitaxel.

FDA pregnancy category D. This medication can cause harm to an unborn baby. Do not receive paclitaxel without telling your doctor if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment. It is not known whether paclitaxel passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is paclitaxel given?

Paclitaxel is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion, and can take up to 24 hours to complete.

Paclitaxel is usually given every 3 weeks. Follow your doctor's instructions.

Before your injection, you may be given other medications to help prevent a serious allergic reaction to paclitaxel.

Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.

If any of this medication gets on your skin, wash the area with soap and warm water right away.

Your breathing, blood pressure, oxygen levels, and other vital signs will be watched closely while you are receiving paclitaxel.

Your heart rate may also be monitored through electrocardiograph or ECG (sometimes called an EKG). This machine measures electrical activity of the heart.

Paclitaxel can lower blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Do not miss any scheduled appointments.

What happens if I miss a dose?

Contact your doctor if you miss an appointment for your paclitaxel injection.

What happens if I overdose?

Seek emergency medical attention if you think you have received too much of this medicine.

Overdose symptoms may include numbness or tingling, fever, chills, mouth sores, unusual bleeding or weakness, or any signs of infection.

What should I avoid while using Onxol (paclitaxel)?

Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are being treated with paclitaxel.

Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.

Onxol (paclitaxel) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

• 
  

  slow heart rate;

  
  


• 
  

  seizure (black-out or convulsions);

  
  


• 
  

  pale skin, easy bruising or bleeding, unusual weakness;

  
  


• 
  

  fever, chills, body aches, flu symptoms;

  
  


• 
  

  white patches or sores inside your mouth or on your lips;

  
  


• 
  

  numbness, tingling, or burning pain in your hands or feet;

  
  


• 
  

  increased blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats); or

  
  


• 
  

  warmth or redness under your skin.

  
  

Less serious side effects may include:

• 
  

  pain, swelling, redness, or skin color changes where the medicine was injected;

  
  


• 
  

  joint or muscle pain;

  
  


• 
  

  mild nausea, vomiting, diarrhea; or

  
  


• 
  

  hair loss.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Onxol (paclitaxel)?

There are many other medicines that can interact with paclitaxel. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor. Keep a list with you of all the medicines you use and show this list to any doctor or other healthcare provider who treats you.

More Onxol resources

• Onxol Side Effects (in more detail)
• Onxol Use in Pregnancy & Breastfeeding
• Onxol Drug Interactions
• Onxol Support Group
• 0 Reviews for Onxol - Add your own review/rating

• Onxol Prescribing Information (FDA)


• Onxol MedFacts Consumer Leaflet (Wolters Kluwer)


• Onxol Advanced Consumer (Micromedex) - Includes Dosage Information


• Paclitaxel Prescribing Information (FDA)


• Paclitaxel Professional Patient Advice (Wolters Kluwer)


• Paclitaxel Monograph (AHFS DI)


• Paclitaxel MedFacts Consumer Leaflet (Wolters Kluwer)


• Taxol Prescribing Information (FDA)


• Taxol Consumer Overview

Compare Onxol with other medications

• Breast Cancer
• Breast Cancer, Adjuvant
• Breast Cancer, Metastatic
• Kaposi's Sarcoma
• Non-Small Cell Lung Cancer
• Ovarian Cancer
• Wilms' Tumor

Where can I get more information?

• Your doctor or pharmacist can provide more information about paclitaxel.

See also: Onxol side effects (in more detail)

Zideron

Zideron may be available in the countries listed below.

Ingredient matches for Zideron

Dextropropoxyphene

Dextropropoxyphene hydrochloride (a derivative of Dextropropoxyphene) is reported as an ingredient of Zideron in the following countries:

• Greece

International Drug Name Search

Ondansetron Nycomed

Ondansetron Nycomed may be available in the countries listed below.

Ingredient matches for Ondansetron Nycomed

Ondansetron

Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Ondansetron Nycomed in the following countries:

• Norway


• Switzerland

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondansetron Nycomed in the following countries:

• Denmark


• Sweden

International Drug Name Search

Sevredol

Sevredol may be available in the countries listed below.

UK matches:

• Sevredol tablets 10mg 20mg and 50mg
• Sevredol tablets 10mg, 20mg and 50mg (SPC)

Ingredient matches for Sevredol

Morphine

Morphine is reported as an ingredient of Sevredol in the following countries:

• Latvia

Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of Sevredol in the following countries:

• Australia


• Croatia (Hrvatska)


• Czech Republic


• Estonia


• France


• Germany


• Hungary


• Ireland


• New Zealand


• Poland


• Portugal


• Romania


• Slovakia


• Slovenia


• Spain


• Switzerland


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Koleskol

Koleskol may be available in the countries listed below.

Ingredient matches for Koleskol

Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Koleskol in the following countries:

• Indonesia

International Drug Name Search

Kaltide

Kaltide may be available in the countries listed below.

Ingredient matches for Kaltide

Amiloride

Amiloride hydrochloride dihydrate (a derivative of Amiloride) is reported as an ingredient of Kaltide in the following countries:

• Bangladesh

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Kaltide in the following countries:

• Bangladesh

International Drug Name Search

Ketoconazol A

Ketoconazol A may be available in the countries listed below.

Ingredient matches for Ketoconazol A

Ketoconazole

Ketoconazole is reported as an ingredient of Ketoconazol A in the following countries:

• Netherlands

International Drug Name Search

Rispéridone Teva

Rispéridone Teva may be available in the countries listed below.

Ingredient matches for Rispéridone Teva

Risperidone

Risperidone is reported as an ingredient of Rispéridone Teva in the following countries:

• France

International Drug Name Search

Acetadote

Acetadote is a brand name of acetylcysteine, approved by the FDA in the following formulation(s):

ACETADOTE (acetylcysteine - injectable; intravenous)

• 
  Manufacturer: CUMBERLAND PHARMS
  
  Approval date: January 23, 2004
  
  Strength(s): 6GM/30ML (200MG/ML) ^[RLD]

Has a generic version of Acetadote been approved?

No. There is currently no therapeutically equivalent version of Acetadote available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Acetadote. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Acetadote.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • January 23, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Acetadote Consumer Information (Drugs.com)
• Acetylcysteine Solution Consumer Information (Wolters Kluwer)
• Acetylcysteine inhalation Consumer Information (Cerner Multum)
• Acetylcysteine Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Acetylcysteine AHFS DI Monographs (ASHP)

Antazoline Sulphate

Antazoline Sulphate may be available in the countries listed below.

Ingredient matches for Antazoline Sulphate

Antazoline

Antazoline Sulphate (BANM) is known as Antazoline in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Biomectin

Biomectin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biomectin

Ivermectin

Ivermectin is reported as an ingredient of Biomectin in the following countries:

• Poland

International Drug Name Search

Zinc Oligosol

Zinc Oligosol may be available in the countries listed below.

Ingredient matches for Zinc Oligosol

Zinc Gluconate

Zinc Gluconate is reported as an ingredient of Zinc Oligosol in the following countries:

• France

International Drug Name Search

Kimotab

Kimotab may be available in the countries listed below.

Ingredient matches for Kimotab

Bromelains

Bromelains is reported as an ingredient of Kimotab in the following countries:

• Japan

Trypsin

Trypsin is reported as an ingredient of Kimotab in the following countries:

• Japan

International Drug Name Search

Opana

Generic Name: oxymorphone (Oral route)

ox-i-MOR-fone

Oral route(Tablet, Extended Release)

Opana(R) ER contains oxymorphone, a Schedule II controlled substance with an abuse liability similar to other opioid analgesics. Opana(R) ER is an extended-release oral formulation of oxymorphone indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time; not indicated for use as an as needed analgesic. Extended release tablets should be swallowed whole; not cut, broken, chewed, dissolved, or crushed. Avoid alcohol and alcohol-containing medications as consumption of alcohol may result in increased plasma levels and a potentially fatal overdose of oxymorphone .

Commonly used brand name(s)

In the U.S.

• Opana


• Opana ER

Available Dosage Forms:

• Tablet, Extended Release


• Tablet

Therapeutic Class: Analgesic

Chemical Class: Opioid

Uses For Opana

Oxymorphone tablets are used to relieve pain. The extended-release tablets are used to relieve moderate to severe pain.

Oxymorphone belongs to the group of medicines called narcotic analgesics (pain medicines). It acts in the central nervous system (CNS) to relieve pain. Many of its side effects are also caused by actions in the CNS.

When oxymorphone is used for a long time, it may become habit-forming (causing mental or physical dependence). However, people who have continuing pain should not let the fear of dependence keep them from using narcotics to relieve their pain. Mental dependence (addiction) is not likely to occur when narcotics are used for this purpose. Physical dependence may lead to withdrawal side effects if treatment is stopped suddenly. However, severe withdrawal side effects can usually be prevented by gradually reducing the dose over a period of time before treatment is stopped completely.

This medicine is available only with your doctor's prescription.

Before Using Opana

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of oxymorphone in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of oxymorphone in the elderly. However, elderly patients are more likely to have age-related liver, kidney or heart problems, which may require caution and an adjustment in the dose for patients receiving oxymorphone.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Naltrexone

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Adinazolam


• Alfentanil


• Alprazolam


• Amobarbital


• Anileridine


• Aprobarbital


• Bromazepam


• Brotizolam


• Buprenorphine


• Butabarbital


• Butalbital


• Butorphanol


• Carisoprodol


• Chloral Hydrate


• Chlordiazepoxide


• Chlorzoxazone


• Clobazam


• Clonazepam


• Clorazepate


• Codeine


• Dantrolene


• Dezocine


• Diazepam


• Estazolam


• Ethchlorvynol


• Fentanyl


• Flunitrazepam


• Flurazepam


• Fospropofol


• Halazepam


• Hydrocodone


• Hydromorphone


• Ketazolam


• Levorphanol


• Lorazepam


• Lormetazepam


• Medazepam


• Meperidine


• Mephenesin


• Mephobarbital


• Meprobamate


• Metaxalone


• Methocarbamol


• Methohexital


• Midazolam


• Morphine


• Morphine Sulfate Liposome


• Nalbuphine


• Nitrazepam


• Nordazepam


• Opium


• Oxazepam


• Oxycodone


• Oxymorphone


• Pentazocine


• Pentobarbital


• Phenobarbital


• Prazepam


• Propoxyphene


• Quazepam


• Remifentanil


• Secobarbital


• Sodium Oxybate


• Sufentanil


• Tapentadol


• Temazepam


• Thiopental


• Triazolam

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following is usually not recommended, but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.

• Ethanol

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Addison's disease (adrenal gland problem) or


• Alcohol abuse, or history of or


• Breathing or lung problems (e.g., chronic obstructive pulmonary disease [COPD], cor pulmonale, hypercapnia, hypoxia, sleep apnea) or


• CNS depression, history of or


• Drug dependence, especially narcotic abuse or dependence, history of or


• Enlarged prostate (BPH, prostatic hypertrophy) or


• Hypothyroidism (an underactive thyroid) or


• Kyphoscoliosis (curvature of spine that can cause breathing problems) or


• Mental illness, or history of or


• Obesity, severe or


• Problems with passing urine—Use with caution. May increase risk for more serious side effects.

• Brain tumor or


• Head injury or


• Increased pressure in your head—Some of the side effects of oxymorphone can cause serious problems in people who have these medical problems.

• Breathing problems (e.g., asthma, hypercarbia) or


• Liver disease, moderate to severe or


• Respiratory depression (very slow breathing)—Should not be used in patients with these conditions.

• Gallbladder disease or


• Hypotension (low blood pressure) or


• Hypovolemia (low blood volume) or


• Pancreatitis (inflammation or swelling of the pancreas) or


• Seizures, history of—Use with caution. May make these conditions worse.

• Kidney disease or


• Liver disease, mild—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

• Paralytic ileus (intestine stops working and may be blocked)—Opana® ER should not be given in patients with this condition.

• Shock—Blood pressure–lowering effects of this medicine may be increased.

Proper Use of oxymorphone

This section provides information on the proper use of a number of products that contain oxymorphone. It may not be specific to Opana. Please read with care.

Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. This is especially important for elderly patients, who may be more sensitive to the effects of pain medicines. If too much of this medicine is taken for a long time, it may become habit-forming (causing mental or physical dependence).

It is best to take this medicine on an empty stomach, at least 1 hour before or 2 hours after a meal.

If you are using the extended-release tablets:

• Take the tablets whole, one tablet at a time, with enough water to ensure complete swallowing immediately after placing in the mouth. Do not break, cut, crush, dissolve, lick, or chew it.


• While taking this medicine, part of the tablet may pass into your stools. This is normal and is nothing to worry about.


• This medicine comes with a medication guide. Read and follow these instructions carefully. Ask your doctor if you have any questions.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For oral dosage form (extended-release tablets):
  
  • For moderate to severe pain:
    
    • For patients who are not taking narcotic medicines:
      
      • Adults—At first, 5 milligrams (mg) every 12 hours. Your doctor may adjust your dose as needed.
      
      
      • Children—Use and dose must be determined by your doctor.
      
      
    
    
    • For patients switching from Opana® to Opana® ER:
      
      • Adults—At first, the dose is half of the total oral Opana® that you are taking per day, every 12 hours. Your doctor may adjust your dose as needed.
      
      
      • Children—Use and dose must be determined by your doctor.
      
      
    
    
    • For patients switching from oxymorphone injection to Opana® ER:
      
      • Adults—At first, the dose is 10 times the total oxymorphone injection dose that you are receiving per day divided into two equal doses. Your doctor may adjust your dose as needed.
      
      
      • Children—Use and dose must be determined by your doctor.
      
      
    
    
    • For patients switching from oral opioids to Opana® ER:
      
      • Adults—At first, the dose is half of the total daily dose that you are taking per day, every 12 hours. Your doctor may adjust your dose as needed.
      
      
      • Children—Use and dose must be determined by your doctor.
      
      
    
    
  
  


• For oral dosage form (tablets):
  
  • For pain:
    
    • Adults—At first, 5 milligrams (mg) every 4 to 6 hours. Your doctor may adjust your dose if needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  

Missed Dose

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Oxymorphone can cause serious unwanted effects if taken by adults who are not used to strong narcotic pain medicines, children, or pets. Make sure you store the medicine in a safe and secure place to prevent others from getting it.

Flush all unused medicine down the toilet after you have finished your treatment. Also flush old medicine after the expiration date has passed. This medicine is one of only a few medicines that should be disposed of this way.

Precautions While Using Opana

If you will be taking this medicine for a long time, it is very important that your doctor check you at regular visits for any problems or unwanted effects that may be caused by this medicine.

Oxymorphone may increase your risk of having serious breathing problems. Check with your doctor right away if you are having difficult or troubled breathing; irregular, fast, slow, or shallow breathing; pale or blue lips, fingernails, or skin; or shortness of breath.

This medicine will add to the effects of alcohol and other CNS depressants (medicines that can make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; other prescription pain medicine or narcotics; medicine for seizures or barbiturates; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the other medicines listed above while you are using this medicine.

Oxymorphone may cause some people to become drowsy, dizzy, or lightheaded, or to feel a false sense of well-being. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy, not alert, or lightheaded.

Dizziness, lightheadedness, or even fainting may occur when you get up suddenly from a lying or sitting position. Getting up slowly may help lessen this problem. Also, lying down for a while may relieve dizziness or lightheadedness.

Using this medicine for a long time can cause severe constipation. To prevent this, your doctor may direct you to take laxatives, drink a lot of fluids, or increase the amount of fiber in your diet. Be sure to follow the directions carefully, because continuing constipation can lead to more serious problems.

Before having any kind of surgery (including dental surgery) or emergency treatment, tell the medical doctor or dentist in charge that you are using this medicine. Serious side effects can occur if your medical doctor or dentist gives you certain other medicines without knowing that you are using oxymorphone.

If you have been using this medicine regularly for several weeks or more, do not change your dose or suddenly stop using it without first checking with your doctor. Your doctor may want you to gradually reduce the amount you are taking before stopping it completely. Withdrawal side effects may occur when the medicine is stopped suddenly because your body has become used to this medicine.

Using this medicine while you are pregnant may cause neonatal withdrawal syndrome in your newborn babies. Tell your doctor right away if your baby has the following symptoms: abnormal sleep pattern, diarrhea, high-pitched cry, irritability, shakiness or tremor, weight loss, vomiting, or failure to gain weight.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Opana Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Less common

• Blurred vision


• confusion


• decreased urination


• difficult or labored breathing


• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position


• dry mouth


• fast, pounding, racing, or irregular heartbeat or pulse


• headache


• nervousness


• pounding in the ears


• rapid breathing


• shortness of breath


• sunken eyes


• sweating


• swelling of the hands, ankles, or feet


• thirst


• tightness in the chest


• unusual tiredness or weakness


• wheezing


• wrinkled skin

Rare

• Abdominal or stomach pain


• chest pain or discomfort


• chills


• cold sweats


• cough


• decrease in consciousness


• decrease in urine volume


• difficulty in passing urine (dribbling)


• difficulty with sleeping


• difficulty with swallowing


• disorientation


• drowsiness to profound coma


• fear


• fever


• hallucination


• hives


• hyperventilation


• hoarseness


• irregular, slow, or shallow breathing


• irritability


• irritation


• itching


• joint pain, stiffness, or swelling


• lethargy


• mood or other mental changes


• painful urination


• pale or blue lips, fingernails, or skin


• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue


• redness of the skin


• restlessness


• severe constipation


• severe vomiting


• shaking


• shortness of breath


• skin rash


• swelling of the eyelids, face, or lips


• trouble in holding or releasing urine


• trouble with sleeping


• troubled breathing or swallowing

Get emergency help immediately if any of the following symptoms of overdose occur:

Symptoms of overdose

• Cold and clammy skin


• constricted, pinpoint, or small pupils (black part of the eye)


• decreased awareness or responsiveness


• muscle weakness


• no blood pressure or pulse


• not breathing


• severe sleepiness or unusual drowsiness


• stopping of heart

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Difficulty having a bowel movement (stool)


• feeling of constant movement of self or surroundings


• increased sweating


• nausea or vomiting


• relaxed and calm


• sensation of spinning


• sleepiness

Less common

• Acid or sour stomach


• belching


• decreased appetite


• decreased weight


• diarrhea


• discouragement


• excess air or gas in the stomach or intestines


• feeling of warmth


• feeling sad or empty


• full or bloated feeling


• heartburn


• indigestion


• lack of appetite


• loss of interest or pleasure


• passing gas


• pressure in the stomach


• redness of the face, neck, arms, and occasionally, upper chest


• sleeplessness


• stomach discomfort or upset


• swelling of the abdominal or stomach area


• tiredness


• trouble concentrating


• unable to sleep

Rare

• Blistering, crusting, irritation, itching, or reddening of the skin


• cracked, dry, scaly skin


• difficulty with thinking or concentrating


• disturbed color perception


• double vision


• false or unusual sense of well-being


• feeling jittery


• halos around lights


• loss of vision


• mental depression


• night blindness


• nightmares or unusually vivid dreams


• overbright appearance of lights


• sudden sweating


• tunnel vision


• welts

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Opana side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Opana resources

• Opana Side Effects (in more detail)
• Opana Use in Pregnancy & Breastfeeding
• Drug Images
• Opana Drug Interactions
• Opana Support Group
• 57 Reviews for Opana - Add your own review/rating

• Opana Consumer Overview


• Opana Prescribing Information (FDA)


• Opana MedFacts Consumer Leaflet (Wolters Kluwer)


• Opana Monograph (AHFS DI)


• Oxymorphone Prescribing Information (FDA)


• Oxymorphone MedFacts Consumer Leaflet (Wolters Kluwer)


• Opana ER Extended-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• Opana ER Prescribing Information (FDA)

Compare Opana with other medications

• Labor Pain
• Pain